Renaissance Technologies’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7.57M | Sell |
208,300
-91,300
| -30% | -$3.32M | 0.01% | 1258 |
|
|
2025
Q1 | $10.8M | Buy |
299,600
+44,900
| +18% | +$1.63M | 0.02% | 967 |
|
|
2024
Q4 | $10.7M | Buy |
254,700
+72,600
| +40% | +$3.05M | 0.02% | 979 |
|
|
2024
Q3 | $10.1M | Buy |
+182,100
| New | +$10.1M | 0.02% | 1030 |
|
|
2023
Q3 | – | Sell |
-19,600
| Closed | -$904K | – | 4023 |
|
|
2023
Q2 | $904K | Buy |
+19,600
| New | +$904K | ﹤0.01% | 2532 |
|
|
2022
Q1 | – | Sell |
-47,400
| Closed | -$3.99M | – | 4388 |
|
|
2021
Q4 | $3.99M | Sell |
47,400
-24,200
| -34% | -$2.04M | 0.01% | 1668 |
|
|
2021
Q3 | $6.46M | Sell |
71,600
-390,800
| -85% | -$35.2M | 0.01% | 1307 |
|
|
2021
Q2 | $44.1M | Buy |
462,400
+317,600
| +219% | +$30.3M | 0.06% | 376 |
|
|
2021
Q1 | $16.5M | Buy |
144,800
+50,000
| +53% | +$5.69M | 0.02% | 892 |
|
|
2020
Q4 | $13.1M | Buy |
+94,800
| New | +$13.1M | 0.01% | 989 |
|
|
2016
Q2 | – | Sell |
-54,400
| Closed | -$3.44M | – | 3477 |
|
|
2016
Q1 | $3.44M | Buy |
+54,400
| New | +$3.44M | 0.01% | 1895 |
|
|
2015
Q4 | – | Sell |
-3,200
| Closed | -$308K | – | 3401 |
|
|
2015
Q3 | $308K | Buy |
+3,200
| New | +$308K | ﹤0.01% | 2761 |
|